Literature DB >> 31392194

Nutrition and exercise in Pompe disease.

Mark A Tarnopolsky1, Mats I Nilsson1.   

Abstract

The current standard of care for Pompe disease (PD) is the administration of enzyme replacement therapy (ERT). Exercise and nutrition are often considered as complementary strategies rather than "treatments" per se. Nutritional assessment is important in patients with locomotor disability because the relative hypodynamia limits energy expenditure and thus the total amount of energy must be reduced to avoid obesity. A lower total energy intake often leads to lower protein and micronutrient intake. Consequently, ensuring that Pompe patients are tested for and replaced for deficiencies (protein, vitamin D, vitamin B12, etc.) is an important aspect of care. Furthermore, given the role of autophagy in the pathophysiology of PD and the fact that fasting induces autophagy, it is important that strategies such as nutritional timing and amino acid intake (L-arginine, L-leucine) be evaluated as therapies. Exercise interventions have been shown to improve six-minute walk testing distance by more than what was seen in the seminal ERT study in late-onset PD. Exercise therapy can also activate autophagy, and this is likely another component of its efficacy. The current review will evaluate the theoretical and practical aspects of nutrition and exercise as therapies for patients with PD.

Entities:  

Keywords:  Protein intake; autophagy; diet; endurance; exercise training; strength

Year:  2019        PMID: 31392194      PMCID: PMC6642937          DOI: 10.21037/atm.2019.05.52

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  128 in total

1.  Stimulation of myofibrillar synthesis by exercise is mediated by more efficient translation of mRNA.

Authors:  S Welle; K Bhatt; C A Thornton
Journal:  J Appl Physiol (1985)       Date:  1999-04

Review 2.  Limiting factors for maximum oxygen uptake and determinants of endurance performance.

Authors:  D R Bassett; E T Howley
Journal:  Med Sci Sports Exerc       Date:  2000-01       Impact factor: 5.411

3.  Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study.

Authors:  M C Walter; H Lochmüller; P Reilich; T Klopstock; R Huber; M Hartard; M Hennig; D Pongratz; W Müller-Felber
Journal:  Neurology       Date:  2000-05-09       Impact factor: 9.910

4.  Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients.

Authors:  M L C Hagemans; L P F Winkel; P A Van Doorn; W J C Hop; M C B Loonen; A J J Reuser; A T Van der Ploeg
Journal:  Brain       Date:  2005-01-19       Impact factor: 13.501

5.  Musculoskeletal fitness and risk of mortality.

Authors:  Peter T Katzmarzyk; Cora L Craig
Journal:  Med Sci Sports Exerc       Date:  2002-05       Impact factor: 5.411

6.  Effects of high-intensity resistance training on untrained older men. I. Strength, cardiovascular, and metabolic responses.

Authors:  F C Hagerman; S J Walsh; R S Staron; R S Hikida; R M Gilders; T F Murray; K Toma; K E Ragg
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-07       Impact factor: 6.053

7.  Body mass index, physical inactivity and low level of physical fitness as determinants of all-cause and cardiovascular disease mortality--16 y follow-up of middle-aged and elderly men and women.

Authors:  N Haapanen-Niemi; S Miilunpalo; M Pasanen; I Vuori; P Oja; J Malmberg
Journal:  Int J Obes Relat Metab Disord       Date:  2000-11

8.  Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy.

Authors:  M A Tarnopolsky; D J Mahoney; J Vajsar; C Rodriguez; T J Doherty; B D Roy; D Biggar
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

9.  Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study.

Authors:  Maggie C Walter; Peter Reilich; Hanns Lochmüller; Ralph Kohnen; Beate Schlotter; Hubert Hautmann; Elmar Dunkl; Dieter Pongratz; Wolfgang Müller-Felber
Journal:  J Neurol       Date:  2002-12       Impact factor: 4.849

10.  Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.

Authors:  Mark Tarnopolsky; Douglas Mahoney; Terry Thompson; Heather Naylor; Timothy J Doherty
Journal:  Muscle Nerve       Date:  2004-01       Impact factor: 3.217

View more
  2 in total

1.  A Newborn Screening, Presymptomatically Identified Infant With Late-Onset Pompe Disease: Case Report, Parental Experience, and Recommendations.

Authors:  Raymond Y Wang
Journal:  Int J Neonatal Screen       Date:  2020-03-14

2.  Dietary Protein and Amino Acid Deficiency Inhibit Pancreatic Digestive Enzyme mRNA Translation by Multiple Mechanisms.

Authors:  Maria Dolors Sans; Stephen J Crozier; Nancy L Vogel; Louis G D'Alecy; John A Williams
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.